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ABSTRACT
Objectives: The purpose of the research is to develop a simple, precise, economical, accurate, reproducible, and sensitive method for the estimation of 
methylcobalamin, alpha-lipoic acid, pyridoxine hydrochloride, and folic acid drug product by reversed-phase high-performance liquid chromatography 
(RP-HPLC) method.
Methods: New analytical method was developed for the estimation of methylcobalamin, alpha-lipoic acid, pyridoxine hydrochloride, and folic acid 
in drug product by RP-HPLC. The chromatographic separation was achieved on the Inertsil C18, 250 mm × 4.6 mm, 5 µm at ambient temperature. 
The separation achieved employing a mobile phase consists of buffer (added 5.05 g hexane-1-sulfonic acid is dissolved into 1000 mL of distilled 
water):acetonitrile in the ratio of 10:90% v/v. The flow rate was 1 mL/min and UV-visible spectrophotometer at 285 nm. The average retention time 
for methylcobalamin, alpha-lipoic acid, pyridoxine hydrochloride, and folic acid was found to be 3.5, 6.7, 8.5, and 9.3, respectively.
Results: The developed method was validated as per ICH guidelines. All validation parameters were within the acceptable ranges. The assay methods 
were found to be linear from 0 to 2130 µg/mL for methylcobalamin, 0 to 142.5 μg/mL for alpha-lipoic acid, 0–4.54 µg/mL for pyridoxine hydrochloride, 
and 0–2 µg/mL for folic acid. The correlation coefficient was 0.999 for all drugs, respectively. The mean percentage values for the developed method 
were found to be within the range of 98–100.6%. The developed method was also found to be robust.
Conclusion: It is concluded that developed method was accurate, precise, linear, reproducible, robust, and sensitive.
Keywords: Alpha-lipoic acid, Folic acid, Methylcobalamin, Pyridoxine hydrochloride and Reversed-phase high-performance liquid chromatography, 
Validation.
INTRODUCTION
Methylcobalamin is a cobalamin, a form of Vitamin B12. It differs from 
cyanocobalamin in that the cyano at the cobalt is replaced with a methyl 
group [1] and is chemically Coα-[α-(5,6-dimethylbenz-1H-imidazolyl)]-
Coβmethyl cob amide. Methylcobalamin is also used in the treatment 
of peripheral neuropathy, diabetic neuropathy, and as a preliminary 
treatment for amyotrophic lateral sclerosis [2]. The alpha-lipoic acid is 
chemically (R)-5-(1,2-dithiolan-3-yl)pentatonic acid. Alpha-lipoic acid 
is easily absorbed and transported across cell membranes; thus, free 
radical protection occurs both inside and outside of cells. Pyridoxine, 
also known as Vitamin B6, is a form of Vitamin B6 found commonly in 
food and used as dietary supplement [3]. Pyridoxine responsiveness 
is associated with two particular missense mutations in the AGT gene 
which lead to Gly170Arg and Phe152Ile amino acid replacements [4-6]. 
Folic acid, also known as Vitamin B9, is a form of synthetically produced 
water-soluble vitamin found in fortified food and supplements. Folate 
is naturally derived from food, particularly from dark green leafy 
vegetables [7]. Folate and the biologically active folic acid, which is 
converted to dihydrofolic acid in the liver, are essential in meeting 
the requirements of the function of the human body. Folate is used to 
synthesize, repair, and methylate deoxyribonucleic acid [8]. According to 
literature review some methods are developed and validated by using 
different techniques like High performance liquid chromatography 
[9,10], ultra performance liquid chromatography [11], ultravoilet-
visible [12] technique with other combination of drugs. The proposed 
method aimed to develop and validate a stability-indicating method 
for the estimation of methylcobalamin, alpha-lipoic acid, pyridoxine 
hydrochloride, and folic acid in bulk and combined dosage form by 
reverse-phase high-performance liquid chromatography (Figs. 1-4).
MATERIALS AND METHODS
Equipment
The chromatographic technique was performed on a Waters, 2695 
separation module, Empower, Version 2.0, reversed-phase C18 column 
(Inertsil, 250 mm × 4.6 mm, 5 µm) as stationary phase, with Sartorius 
analytical balance and vacuum microfiltration unit with 0.45 μ 
membrane filter.
Materials
Pharmaceutically pure samples of methylcobalamin, alpha-lipoic acid, 
pyridoxine hydrochloride, and folic acid were obtained from ICON 
Laboratories, Vijayawada, India.
High-performance liquid chromatography grade methanol and 
acetonitrile were procured from on laboratories, Vijayawada, India.
Selection of wavelength (for detection)
In setting up the conditions for the development of assay method, the 
choice of detection wavelength was based on the scanned absorption 
spectrum for methylcobalamin, alpha-lipoic acid, pyridoxine 
hydrochloride, and folic acid. The UV spectrum of methylcobalamin, 
alpha-lipoic acid, pyridoxine hydrochloride, and folic acid was obtained 
© 2018 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
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separately by scanning the sample over the wavelength range of 200–
400 nm against blank as methanol. After thorough examination of the 
spectra, the wavelength 260 nm was selected for further analysis. The 
overlay spectrum for methylcobalamin, alpha-lipoic acid, pyridoxine 
hydrochloride, and folic acid is shown in Fig. 5.
Chromatographic conditions
The sample separation was achieved on a C18 (Inertsil, 250 mm 
× 4.6 mm, 5 µm) column, aided by mobile phase mixture of 
buffer: acetonitrile (10:90%v/v). The flow rate was 1 mL/min and 
ultraviolet detector at 285 nm, injection volume is 10 μL and maintained 
at ambient temperature.
Preparation of mobile phase
Buffer preparation: An accurate amount of 5.05 g hexane-1-sulfonic 
acid is dissolved into 1000-mL distilled water and adjusted to pH - 2.5 
with OPA. Then it was filtered through 0.45-μ membrane filter.
Mobile phase: Then, 10 volumes of buffer and 90 volumes of acetonitrile 
were added and sonicated for 10 min.
Preparation of standard stock solution
Weighed accurately about 1500 mg methylcobalamin, 100 mg alpha-
lipoic acid, 3 mg of pyridoxine, and 1.5 mg folic acid and transferred 
into 100-mL volumetric flask, added 70 mL of diluent, sonicated to 
dissolve, and diluted up to volume with diluents to give a primarily 
stock solution containing 150 µg/mL of methylcobalamin, 10 µg/mL of 
alpha-lipoic acid, 0.3 μg/mL of pyridoxine hydrochloride, and 15 μg/mL 
of folic acid.
Fig. 1: Chemical structure of methylcobalamin
Fig. 2: Chemical structure of alpha-lipoic acid
Fig. 3: Chemical structure of pyridoxine hydrochloride
Fig. 5: UV spectrum of methylcobalamin, alpha-lipoic acid, 
pyridoxine HCL, and folic acid (285 nm)
Fig. 4: Chemical structure of folic acid
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Sample solution
Accurately weighed 10 tablets were crushed to powdered form and then 
five tablets equivalent of sample were taken into a 250-mL volumetric 
flask. To this, 200 mL of diluent was added, sonicated to dissolve, and 
diluted to volume diluent and further diluted to 5–100 mL with the 
diluents, which was filtered through 0.45-μ Nylon syringe filter.
Method validation
System suitability
The typical values for evaluating system suitability of a chromatographic 
procedure are relative standard deviation (RSD) <2%, tailing factor 
<2%, and theoretical plates >2000. The retention time, peak area, 
theoretical plates, and tailing factor were evaluated for the system.
Linearity
Linearity was studied by analyzing five standard solutions covering 
the range from 0 to 2130 µg/mL for methylcobalamin, 0–142.5 µg/mL 
for alpha-lipoic acid, 0–4.54 µg/mL for pyridoxine hydrochloride, and 
0–2 µg/mL for folic acid. A calibration curve with concentration versus 
peak area was plotted by injecting the above-prepared solutions.
Robustness
Robustness is the measure of method remains unaffected by small 
deliberate changes in method parameters such as flow rate and detection 
of wavelength on assay of the analyte of interest. Here, the detection 
wavelength varied ±2 nm and flow rate was varied ±0.1 mL/min.
Solution stability
The solution stability of methylcobalamin, alpha-lipoic acid, 
pyridoxine hydrochloride, and folic acid in diluents was determined 
by storing sample solution in a tightly capped volumetric flask at room 
temperature for 24h. The amount of methylcobalamin, alpha-lipoic acid, 
pyridoxine hydrochloride, and folic acid was measured at different time 
intervals such as 12 and 24 h, and the results obtained were compared 
methylcobalamin, alpha-lipoic acid, pyridoxine hydrochloride, and folic 
acid freshly prepared solutions.
RESULTS AND DISCUSSION
Selection of wavelength (for detection)
System suitability
The system suitability of the method was checked by repeated preparations 
for 160 µg/mL for methylcobalamin, 120 µg/mL for alpha-lipoic acid, 
80 µg/mL for pyridoxine hydrochloride, and 40 µg/mL for folic acid. 
The typical values for evaluating system suitability of a chromatographic 
procedure are RSD <2%, tailing factor <2%, and theoretical plates >2000. 
The retention time, peak area, theoretical plates, and tailing factor were 
evaluated for the system suitability data of methylcobalamin, alpha-lipoic 
acid, pyridoxine hydrochloride, and folic acid are shown in Table 1.
Table 1: System suitability parameters for methylcobalamin, alpha-lipoic acid, pyridoxine hydrochloride, and folic acid
Parameters Methylcobalamin Alpha-lipoic acid Pyridoxine hydrochloride Folic acid Acceptance criteria
Retention time (min) 13.505 14.399 3.544 6.732 ±10
Theoretical plates 43409 19674 117890 3951 >2000
Tailing factor 1.22 1.89 1.61 1.81 <2
RSD 0.777 0.100 0.047 0.047 <2
RSD: Relative standard deviation
Table 2: Method precision values for methylcobalamin
Rt (min) Area USP plate USP tailing
13.505 5962 52654 1.21
13.512 5973 51764 1.27
13.505 5984 45180 1.57
13.512 5945 52104 1.27
13.505 5898 53121 1.21
13.512 5979 51792 1.26
Mean: 5957
%RSD: 0.534
Rt: Retention time, %RSD: Percentage relative standard deviation
Table 3: Method precision values for alpha-lipoic acid
Rt (min) Area USP plate USP tailing
14.399 218860 19674 1.89
14.409 218860 19470 1.88
14.399 218652 19685 1.89
14.409 217920 19518 1.87
14.399 218845 19677 1.89
14.409 218367 19496 1.89
Mean: 218584
%RSD: 0.173
Rt: Retention time, %RSD: Percentage relative standard deviation
Table 4: Method precision values for pyridoxine hydrochloride
Rt (min) Area USP plate USP tailing
3.544 117890 6272 1.33
3.547 117967 6014 1.33
3.544 117478 6274 1.42
3.547 117785 6018 1.36
3.544 117769 6275 1.33
3.547 117967 6014 1.33
Mean: 117809
%RSD: 0.156
Rt: Retention time, %RSD: Percentage relative standard deviation
Table 5: Method precision values for folic acid
Rt (min) Area USP plate USP tailing
6.732 158056 3954 1.81
6.738 158808 3944 1.84
6.732 157872 3957 1.80
6.738 157920 3957 1.84
6.732 158224 3951 1.81
6.738 158808 3944 1.84
Mean: 158281
%RSD: 0.269
Rt: Retention time, %RSD: Percentage relative standard deviation
Table 6: LOD and LOQ values calculated from calibration curve





Alpha-lipoic acid 4.55 13.815
Pyridoxine Hcl 0.087 0.264
Folic acid 0.0447 0.135
LOD: Limit of detection, LOQ: Limit of quantitation, SD: Standard deviation, 
S:  lope
Accuracy
The accuracy of the method was determined by calculating the recoveries of 
methylcobalamin, alpha-lipoic acid, pyridoxine hydrochloride, and 
folic acid by analyzing solutions containing approximately 50%, 100%, 
and  150%  of  the  working  strength  of  methylcobalamin, 
alpha-lipoic acid, pyridoxine hydrochloride, and folic acid.
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Table 7: Accuracy results of methylcobalamin by HPLC
Accuracy Conc. (ppm) Area Amount added Amount recovered % recovery Results
50 50 4994 0.367 0.37 100.8 Mean: 0.28
S.D: 0.280
%RSD: 100
50 50 5111 0.378 0.38 100.5
50 50 5111 0.379 0.38 100.3
100 100 10447 0.781 0.78 99.9 Mean: 0.07
S.D: 0.07
%RSD: 0.070
100 100 10107 0.75 0.75 100.0
100 100 10447 0.78 0.78 100.0
150 150 15482 1.15 1.15 100.9 Mean: 100.3
S.D: 0.51
%RSD: 0.500
150 150 15482 1.15 1.15 100.0
150 150 15146 1.13 1.13 100.0
Mean: 100.2
%RSD: 0.25
Ppm: Parts per million, SD: Standard deviation, %RSD: Percentage relative standard deviation
Table 8: Accuracy results of alpha-lipoic acid by HPLC
Accuracy Conc. (ppm) Area Amount added Amount recovered % recovery Results
50 50 110448 250.7 252.94 100.9 Mean: 100.8
S.D: 0.15
%RSD: 0.150
50 50 110448 251.4 252.94 100.6
50 50 110448 250.8 252.94 100.9
100 100 220245 501.5 504.4 100.6 Mean: 100.5
S.D: 00.25
%RSD: 0.250
100 100 220064 502.8 503.98 100.2
100 100 220064 500.4 503.98 100.7
150 150 331868 759.6 760.03 100.1 Mean: 100.4
S.D: 0.33
%RSD: 0.330
150 150 330680 752.2 757.31 100.7
150 150 330680 753.1 757.31 100.6
Mean: 100.6
%RSD: 0.21
Ppm: Parts per million, SD: Standard deviation, %RSD: Percentage relative standard deviation
Table 9: Accuracy results of pyridoxine hydrochloride by HPLC
Accuracy Conc. (ppm) Area Amount added Amount recovered % recovery Results
50 50 80094 3.79 3.79 100.0 Mean: 100.1
S.D: 0.41
%RSD: 0.400
50 50 80094 3.78 3.79 100.3
50 50 80094 3.76 3.79 100.8
100 100 162301 7.68 7.68 100.0 Mean: 100
S.D: 0.13
%RSD: 0.130
100 100 162301 7.69 7.68 99.9
100 100 162301 7.67 7.68 100.1
150 150 246824 11.59 11.68 100.8 Mean: 100.7
S.D: 0.15
%RSD: 0.150
150 150 248096 11.68 11.74 100.5
150 150 248096 11.65 11.74 100.8
Mean: 100.4
%RSD: 0.35
Ppm: Parts per million, SD: Standard deviation, %RSD: Percentage relative standard deviation
Table 10: Accuracy results of folic acid by HPLC
Accuracy Conc. (ppm) Area Amount added Amount recovered % recovery Results
50 50 80094 3.79 3.79 100.0 Mean: 100.4
S.D: 0.41
%RSD: 0.400
50 50 80094 3.78 3.79 100.3
50 50 80094 3.76 3.79 100.8
100 100 162301 7.68 7.68 100.0 Mean: 100.0
S.D: 0.13
%RSD: 0.130
100 100 162301 7.69 7.68 99.9
100 100 162301 7.67 7.68 100.1
150 150 246824 11.59 11.68 100.8 Mean: 100.7
S.D: 0.15
%RSD: 0.150
150 150 248096 11.68 11.74 100.5
150 150 248096 11.65 11.74 100.8
Mean: 100.4
%RSD: 0.35
Ppm: Parts per million, SD: Standard deviation, %RSD: Percentage relative standard deviation
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Table 11: Robustness data for methylcobalamin, alpha-lipoic acid, pyridoxine HCL, and folic acid
Drug Parameter Retention time Area
Methylcobalamin Decreased flow rate (0.8 mL) 13.506 100178
Increased flow rate (1.2 mL) 13.496 96114
Wavelength (283 nm) 13.506 104399
Wavelength (287 nm) 13.506 92044
Alpha-lipoic acid Decreased flow rate (0.8 mL) 14.404 221198
Increased flow rate (1.2 mL) 14.395 215464
Wavelength (283 nm) 14.404 176205
Wavelength (287 nm) 14.399 258132
Pyridoxine hydrochloride Decreased flow rate (0.8 mL) 3.548 118836
Increased flow rate (1.2 mL) 3.545 117704
Wavelength (283 nm) 3.548 360499
Wavelength (287 nm) 3.550 23881
Folic acid Decreased flow rate (0.8 mL) 3.548 118836
Increased flow rate (1.2 mL) 3.545 117704
Wavelength (283 nm) 13.506 104399
Wavelength (287 nm) 13.505 92044
nm: Nanometer
Table 12: Solution stability of methylcobalamin
Stability (h) Rt Area USP plate count USP tailing % assay
Initial 13.506 99220 47146 1.13 100
6 13.506 99587 47182 1.17 100.5
12 13.506 99220 47146 1.13 100.6
18 13.506 99220 47146 1.13 100.4
24 13.506 99733 47077 1.14 100.6
H: Hours, Rt: Retention time, % assay: Percentage assay
Table 13: Solution stability of alpha-lipoic acid
Stability (h) Rt Area USP plate count USP tailing % assay
Initial 14.404 217168 20032 1.91 100.0
6 14.404 217168 20032 1.91 100.3
12 14.404 216158 20092 1.89 100.3
18 14.404 217690 20002 1.93 101.1
24 14.404 217168 20032 1.91 100.3
H: Hours, Rt: Retention time, % assay: Percentage assay
Table 14: Solution stability of pyridoxine HCL
Stability (h) Rt Area USP plate count USP tailing % assay
Initial 3.548 117699 5824 1.34 100.8
6 3.548 117669 5837 1.32 100.1
12 3.548 117849 5827 1.24 100.4
18 3.548 117391 5834 1.26 100.2
24 3.548 115679 5874 1.30 100.0
H: Hours, Rt: Retention time, % assay: Percentage assay
Table 15: Solution stability of folic acid
Stability (h) Rt Area USP plate count USP tailing % assay
Initial 6.739 158182 3842 1.86 100.2
6 6.739 157546 3855 1.83 100.3
12 6.739 158278 3842 1.85 100.7
18 6.739 158030 3846 1.84 100.4
24 6.739 158535 3837 1.85 100.6
H: Hours, Rt: Retention time, % assay: Percentage assay
Linearity
Linearity was studied by analyzing six concentrations ranging from 
0 to 2130 µg/mL for methylcobalamin, 0 to 142 µg/mL for alpha-
lipoic acid, 0 to 4 µg/mL for pyridoxine hydrochloride, and 0 to 
2 µg/mL for folic acid. A calibration curve with concentration versus 
peak area was plotted by injecting the above-prepared stock solutions. 
Correlation coefficient values for methylcobalamin, alpha-lipoic acid, 
pyridoxine hydrochloride, and folic acid are 0.999, respectively. The 
linear regression data for the calibration plot indicate a good linear 
relationship between peak area and concentration. The linearity data 
for all drugs are shown in Figs. 6-9.
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Precision
The precision of the method was checked by repeated preparations. 
The measurement of peak areas of repeated solutions (n=6) for 
160 µg/mL of methylcobalamin, 120 µg/mL of alpha-lipoic acid, 80 µg/
mL of pyridoxine hydrochloride, and 40 µg/mL of folic acid. The study 
was expressed as RSD of set of results. The precision of the method 
(%RSD) was found to be <1% showing a good repeatability. The values 
of percentage RSD for all drugs are shown in Tables 2-5.
LOD and LOQ
The LOD and LOQ were separately determined based on standard deviation 
of the Y-intercept and slope of the calibration curve. The LOD of the proposed 
method was found to be 40.631 µg/mL, 4.55 µg/mL, 0.087 µg/mL, and 
0.0447 µg/mL and LOQ was found to be 123.12 µg/mL for methylcobalamin, 
13.815 µg/mL for alpha-lipoic acid, 0.264 µg/mL for pyridoxine hydrochloride, 
and 0.135 µg/mL for folic acid. The results are shown in Table 6.
Robustness
Robustness is the measure of a method remains unaffected by small, 
deliberate changes in method parameters such as flow rate and detector 
wavelength on assay of the analyte of interest. Here, the detection 
wavelength varied ±2 nm and flow rate was varied ±0.1 mL/min. The 
results are shown in Table 11.
Solution stability
The amount of methylcobalamin, alpha-lipoic acid, pyridoxine 
hydrochloride, and folic acid was measured at different time intervals 
such as 12 and 24 h, and the results obtained were compared 
methylcobalamin, alpha-lipoic acid, pyridoxine hydrochloride, and folic 
acid freshly prepared solutions. The results are shown in Tables 12-15.
CONCLUSION
From the experimental results and parameters, it was concluded 
that this newly developed method for the simultaneous estimation of 
methylcobalamin, alpha-lipoic acid, pyridoxine hydrochloride, and folic 
acid was found to be simple, precise, and accurate. The high resolution 
and shorter retention time make this method more acceptable and cost-
effective, and it can be effectively applied for routine analysis in research 
institutions, quality control department, and approved testing laboratories.
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Fig. 6: Graph representing calibration curve of methylcobalamin. Error 
bars represent standard deviation of the mean (±standard deviation)
Fig. 7: Graph representing calibration curve of alpha-lipoic acid. Error 
bars represent standard deviation of the mean (±standard deviation)
Fig. 8: Graph representing calibration curve of pyridoxine 
hydrochloride. Error bars represent standard deviation of the 
mean (±standard deviation)
Fig. 9: Graph representing calibration curve of folic acid. Error bars 
represent standard deviation of the mean (±standard deviation)
Accuracy
The accuracy of the method was determined by calculating the recoveries of 
methylcobalamin, alpha-lipoic acid, pyridoxine hydrochloride, and 
folic acid by analyzing solutions containing approximately 50%, 100%, 
and  150%  of  the  working  strength  of  methylcobalamin, 
alpha-lipoic acid, pyridoxine hydrochloride, and folic acid are shown in 
Tables 7-10.
